Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • coralgirl
    Junior Member
    • Nov 2011
    • 6

    DESeq Plot Error

    Hi,

    I'm trying to plot the scatterplot of direct vs. moderated log-ratios and I keep getting an error:

    Error in plot.window(...) : need finite 'ylim' values
    In addition: Warning messages:
    1: In min(x) : no non-missing arguments to min; returning Inf
    2: In max(x) : no non-missing arguments to max; returning -Inf

    This is what I have put in:

    > cdsBlind <- estimateDispersions( cds, method="blind" )
    > vsd <- getVarianceStabilizedData( cdsBlind )
    > mod_lfc <- (rowMeans( vsd[, conditions(cds)=="treated", drop=FALSE] ) -
    + rowMeans( vsd[, conditions(cds)=="untreated", drop=FALSE] ))
    > lfc <- res$log2FoldChange
    > finite <- is.finite(lfc)
    > table(as.character(lfc[!finite]), useNA="always")

    -Inf Inf NaN <NA>
    83 212 285 0
    > largeNumber <- 10
    > lfc <- ifelse(finite, lfc, sign(lfc) * largeNumber)
    > plot( lfc, mod_lfc, pch=20, cex=.3,
    + col = ifelse( finite, "#80808040", "red" ) )

    Is it because I am running analysis on samples with no replicates? (I know - not good, but it's all that I have...). Any ideas? Thanks.
  • Wolfgang Huber
    Senior Member
    • Aug 2009
    • 109

    #2
    Dear Coral Girl

    it looks like your mod_lfc consists of all non-finite values. What are the conditions names in your object cds? Note that in the line

    mod_lfc <- (
    rowMeans( vsd[, conditions(cds)=="treated", drop=FALSE] ) -
    rowMeans( vsd[, conditions(cds)=="untreated", drop=FALSE] ))
    you select columns in the data matrix with the names treated and untreated, and if there are no such columns, rowMeans will return NaN. In this case, you need to modify the above code according to your condition names.

    Hope this helps.
    Wolfgang
    Wolfgang Huber
    EMBL

    Comment

    • coralgirl
      Junior Member
      • Nov 2011
      • 6

      #3
      Hi Wolfgang,

      Thank you very much - that was exactly the problem. A rookie mistake on my behalf!

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
        If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
        This guide explains everything you need to know about...
        Today, 01:13 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...